Theravance Biopharma (TBPH) Other Non-Current Assets (2014 - 2026)

Theravance Biopharma (TBPH) has 13 years of Other Non-Current Assets data on file, last reported at $836000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $836000.0 in Q1 2026; TTM through Mar 2026 was $836000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $24.9 million, up 102.51% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $836000.0, down from $24.9 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for TBPH reached as high as $24.9 million in Q4 2025 and fell as low as $836000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $5.5 million across 5 years, with a median of $836000.0 in 2022.
• Across the five-year window, Other Non-Current Assets soared 1369.62% in 2024 and slumped 89.41% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $836000.0 in 2022, then changed by 0.0% to $836000.0 in 2023, then surged by 1369.62% to $12.3 million in 2024, then surged by 102.51% to $24.9 million in 2025, then tumbled by 96.64% to $836000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $836000.0 in Q1 2026, $24.9 million in Q4 2025, and $836000.0 in Q3 2025.